glp-1 and type 2 diabetes Novel GLP-1–Based Medications for Obesity GLP-1-based therapies for type 2

Lotosky, J., Jean, X., Altankhuyag, A., Khan, S., Bernotas, A., Sharafshah, A., Blum, K., Posner, A., & Thanos, P

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications (SAVOR- TIMI 53)

The strengths of our investigation lie in the methodological rigor and the high number of studies examined

muciniphila would allow for diversification of the gut microbiome

1 Beyond its well-known implications, such as insulin resistance and obesity , PCOS is a leading cause of infertility due to irregular menstrual cycles and hormonal imbalances

Dynamic-covalent hydrogel with NIR-triggered drug delivery for localized chemo-photothermal combination therapy